131 related articles for article (PubMed ID: 33161110)
1. Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway.
Liang Y; Zhang T; Ren L; Jing S; Li Z; Zuo P; Li T; Wang Y; Zhang J; Wei Z
Environ Toxicol Pharmacol; 2021 Jan; 81():103542. PubMed ID: 33161110
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549 cells.
Zhang J; Song Y; Liang Y; Zou H; Zuo P; Yan M; Jing S; Li T; Wang Y; Li D; Zhang T; Wei Z
Food Chem Toxicol; 2019 Oct; 132():110654. PubMed ID: 31265865
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin IIb Extracted from Hemsleya penxianensis Induces Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells by Regulating Cell Cycle Checkpoints and Mitochondrial Apoptotic Pathway.
Chen N; Li P; Liu L; Zhang J; Cao Z; Chen Z; Xu X; Ma G; Huo X
Plant Foods Hum Nutr; 2023 Jun; 78(2):483-492. PubMed ID: 37086373
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
5. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin IIb exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes.
Wang Y; Zhao GX; Xu LH; Liu KP; Pan H; He J; Cai JY; Ouyang DY; He XH
PLoS One; 2014; 9(2):e89751. PubMed ID: 24587010
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin IIb from Ibervillea sonorae Induces Apoptosis and Cell Cycle Arrest via STAT3 Inhibition.
Torres-Moreno H; Marcotullio MC; Velazquez C; Arenas-Luna VM; Hernández-Gutiérrez S; Robles-Zepeda RE
Anticancer Agents Med Chem; 2020; 20(10):1188-1196. PubMed ID: 32294048
[TBL] [Abstract][Full Text] [Related]
8. In vitro antitumor effect of cucurbitacin E on human lung cancer cell line and its molecular mechanism.
Jing SY; Wu ZD; Zhang TH; Zhang J; Wei ZY
Chin J Nat Med; 2020 Jul; 18(7):483-490. PubMed ID: 32616188
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activities of 20(R, S)-protopanaxatriol against epidermal growth factor receptor tyrosine kinase.
Zhao J; Zhang T; Liang Y; Zou H; Zhang J
Food Chem Toxicol; 2021 Sep; 155():112411. PubMed ID: 34271119
[TBL] [Abstract][Full Text] [Related]
10. S5, a Withanolide Isolated from Physalis Pubescens L., Induces G2/M Cell Cycle Arrest via the EGFR/P38 Pathway in Human Melanoma A375 Cells.
Fan Y; Mao Y; Cao S; Xia G; Zhang Q; Zhang H; Qiu F; Kang N
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513793
[TBL] [Abstract][Full Text] [Related]
11. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR - MAPK pathway.
Mahnashi M; Elgazwi SM; Ahmed MS; Halaweish FT
Eur J Med Chem; 2019 Jul; 173():294-304. PubMed ID: 31022583
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
14. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.
Cuadrado A; Garcia-Fernandez LF; Gonzalez L; Suarez Y; Losada A; Alcaide V; Martinez T; Fernandez-Sousa JM; Sanchez-Puelles JM; Munoz A
J Biol Chem; 2003 Jan; 278(1):241-50. PubMed ID: 12414812
[TBL] [Abstract][Full Text] [Related]
15. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
[TBL] [Abstract][Full Text] [Related]
17. Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer.
El Guerrab A; Bamdad M; Kwiatkowski F; Bignon YJ; Penault-Llorca F; Aubel C
Oncotarget; 2016 Nov; 7(45):73618-73637. PubMed ID: 27655662
[TBL] [Abstract][Full Text] [Related]
18. Identification of 20(
Liang Y; Zhao J; Zou H; Zhang J; Zhang T
Oxid Med Cell Longev; 2022; 2022():6119737. PubMed ID: 35111279
[TBL] [Abstract][Full Text] [Related]
19. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
[TBL] [Abstract][Full Text] [Related]
20. Furano-1,2-naphthoquinone inhibits EGFR signaling associated with G2/M cell cycle arrest and apoptosis in A549 cells.
Su JC; Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR
Cell Biochem Funct; 2010 Dec; 28(8):695-705. PubMed ID: 21104938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]